Home Other Building Blocks 30414-53-0
30414-53-0,MFCD00011705
Catalog No.:AA002ZZ5

30414-53-0 | Methyl 3-oxovalerate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$6.00   $4.00
- +
5g
98%
in stock  
$11.00   $8.00
- +
25g
98%
in stock  
$16.00   $11.00
- +
100g
98%
in stock  
$26.00   $18.00
- +
500g
98%
in stock  
$81.00   $57.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002ZZ5
Chemical Name:
Methyl 3-oxovalerate
CAS Number:
30414-53-0
Molecular Formula:
C6H10O3
Molecular Weight:
130.1418
MDL Number:
MFCD00011705
SMILES:
CCC(=O)CC(=O)OC
Properties
Properties
 
BP:
207.8°C at 760 mmHg  
Form:
Liquid  
MP:
-35 °C  
Refractive Index:
n20/D 1.422(lit.)  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
118  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
4  
XLogP3:
0.4  

Upstream Synthesis Route

[1]JournalofHeterocyclicChemistry,1992,vol.29,#5,p.1369-1370

[2]Patent:US5278175,1994,A,

[1]JournalofMedicinalChemistry,2014,vol.57,#6,p.2429-2439

[1]Patent:US5652246,1997,A,

[1]Heterocycles,2000,vol.53,#3,p.549-552

[1]CroaticaChemicaActa,2016,vol.89,#4,

Downstream Synthesis Route

[1]CurrentPatentAssignee:TAKASAGOINTERNATIONALCORPORATION-WO2004/74255,2004,A2Locationinpatent:Page74-75

[2]CurrentPatentAssignee:TAKASAGOINTERNATIONALCORPORATION-WO2004/74255,2004,A2Locationinpatent:Page82-83

[3]CurrentPatentAssignee:TAKASAGOINTERNATIONALCORPORATION-WO2004/74255,2004,A2Locationinpatent:Page83

[4]CurrentPatentAssignee:TAKASAGOINTERNATIONALCORPORATION-WO2004/74255,2004,A2Locationinpatent:Page82

[5]CurrentPatentAssignee:TAKASAGOINTERNATIONALCORPORATION-WO2004/74255,2004,A2Locationinpatent:Page81-82

[6]Bradbury;Allott;Dennis;Fisher;Major;Masek;Oldham;Pearce;Rankine;Revill;Roberts;Russell[JournalofMedicinalChemistry,1992,vol.35,#22,p.4027-4038]

[1]Synthesis,1990,p.382-386

[1]JournalofHeterocyclicChemistry,1992,vol.29,p.1369-1370

[2]Patent:US5278175,1994,A

30414-53-0   
methyl(3R)-3-hydroxypentanoate 
  42558-50-9 

[1]TetrahedronLetters,1986,vol.27,p.2657-2660

[2]TetrahedronLetters,1989,vol.30,p.2245-2246

[3]ChemistryLetters,1987,p.679-682

[4]BulletinoftheChemicalSocietyofJapan,1989,vol.62,p.875-879

[5]ChemistryLetters,1987,p.1267-1270

[6]ChemistryLetters,1987,p.679-682

[7]BulletinoftheChemicalSocietyofJapan,1994,vol.67,p.2473-2477

[8]BulletinoftheChemicalSocietyofJapan,1983,vol.56,p.1414-1419

[9]TetrahedronLetters,1997,vol.38,p.6603-6606

[10]TetrahedronLetters,1990,vol.31,p.267-270

[11]TetrahedronLetters,1989,vol.30,p.2245-2246

[12]ChemistryLetters,1987,p.1267-1270

[13]TetrahedronLetters,1997,vol.38,p.6603-6606

[14]ChemistryLetters,1998,p.1257-1258

[15]JournalofOrganicChemistry,2000,vol.65,p.2586-2587

[16]JournaloftheAmericanChemicalSociety,2001,vol.123,p.1547-1555

[17]BulletinoftheChemicalSocietyofJapan,2002,vol.75,p.355-363

[18]BulletinoftheChemicalSocietyofJapan,2002,vol.75,p.355-363

[19]AngewandteChemie-InternationalEdition,2004,vol.43,p.5066-5069

[20]AdvancedSynthesisandCatalysis,2005,vol.347,p.1978-1986

[21]AdvancedSynthesisandCatalysis,2006,vol.348,p.1157-1160

[22]TetrahedronLetters,2006,vol.47,p.4033-4035

[23]TetrahedronLetters,1985,vol.26,p.4213-4216

[24]AdvancedSynthesisandCatalysis,2003,vol.345,p.160-164

[25]Patent:US6939981,2005,B1.Locationinpatent:Page/Pagecolumn16-17

[26]AdvancedSynthesisandCatalysis,2009,vol.351,p.725-732

[27]AdvancedSynthesisandCatalysis,2013,vol.355,p.209-219

[28]AdvancedSynthesisandCatalysis,2013,vol.355,p.209-219

[29]EuropeanJournalofInorganicChemistry,2017,vol.2017,p.2762-2773

[1]TetrahedronAsymmetry,1991,vol.2,p.569-592

[2]TetrahedronAsymmetry,1994,vol.5,p.675-690

[3]JournalofOrganicChemistry,2004,vol.69,p.7577-7581

[4]ChemicalCommunications,2019,vol.56,p.157-160

[5]EuropeanJournalofOrganicChemistry,2014,vol.2014,p.323-330

[6]EuropeanJournalofOrganicChemistry,2014,vol.2014,p.323-330

[7]Synlett,2011,p.191-194

[8]JournaloftheAmericanChemicalSociety,1987,vol.109,p.5856-5858

[9]TetrahedronLetters,1995,vol.36,p.4801-4804

[10]JournaloftheAmericanChemicalSociety,1995,vol.117,p.4423-4424

[11]Tetrahedron,2001,vol.57,p.2563-2568

[12]JournaloftheAmericanChemicalSociety,2001,vol.123,p.1547-1555

[13]Patent:US6359165,2002,B1.Locationinpatent:Pagecolumn13

[14]Patent:US6939981,2005,B1.Locationinpatent:Page/Pagecolumn14

[15]Patent:US2008/255355,2008,A1.Locationinpatent:Page/Pagecolumn8-9

[16]Patent:US2005/250951,2005,A1.Locationinpatent:Page/Pagecolumn12

[17]Patent:US2005/250951,2005,A1.Locationinpatent:Page/Pagecolumn13

[18]Patent:US2005/250951,2005,A1.Locationinpatent:Page/Pagecolumn12

[19]AdvancedSynthesisandCatalysis,2013,vol.355,p.209-219

[20]Patent:US9250238,2016,B2.Locationinpatent:Page/Pagecolumn106;107;108

[21]CuihuaXuebao/ChineseJournalofCatalysis,2017,vol.38,p.890-897

Literature

Title: 2-Ethyl 4-methyl 5-ethyl-3-methyl-1H-pyrrole-2,4-dicarboxyl-ate.

Journal: Acta crystallographica. Section E, Structure reports online 20120201

Title: Dimethyl 3,5-diethyl-1H-pyrrole-2,4-dicarboxyl-ate.

Journal: Acta crystallographica. Section E, Structure reports online 20110801

Title: Studies on the synthesis and biological activitiy of 6-ethyl-4-aryl-5-methoxycarbonyl-3,4-dihydropyrimidin-2(1H)-ones.

Journal: Arzneimittel-Forschung 20070101

Title: Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers.

Journal: Bioorganic & medicinal chemistry 20061215

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:30414-53-0 Molecular Formula|30414-53-0 MDL|30414-53-0 SMILES|30414-53-0 Methyl 3-oxovalerate